Cardiac catheterization in patients with end‐stage liver disease: Safety and outcomes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Catheterization and cardiovascular interventions

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccd.22591PMID 20506280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation.

  2009cited by this paper
• The two tales of coagulation in liver transplantation

  2008cited by this paper
• Surgical treatment of femoral artery pseudoaneurysms after cardiac catheterization.

  2008cited by this paper
• Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and Treatment

  2007cited by this paper
• Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

  2007cited by this paper
• Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.

  2006cited by this paper
• Coagulation abnormalities in patients who have liver disease.

  2006cited by this paper
• Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.

  2005cited by this paper
• Low bleeding risk from cardiac catheterization in patients with advanced liver disease

  2005cited by this paper
• Hemostatic defects in end stage liver disease.

  2005cited by this paper
• Femoral complications and bed rest duration after coronary arteriography.

  1997cited by this paper
• Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.

  1996cited by this paper

• Coronary Intervention Outcomes in Patients with Liver Cirrhosis

  2025cites this paper
• Cardiovascular disease assessment and management in liver transplantation.

  2024cites this paper
• Safety, risk stratification, and cost of ERCP in patients with cirrhosis: a prospective controlled study

  2024cites this paper
• Liver transplantation: Protocol for recipient selection, evaluation, and assessment

  2023cites this paper
• Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review

  2023cites this paper
• Preoperative Coronary Intervention Before Orthotopic Liver Transplantation (from a Review of Literature).

  2022cites this paper
• Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association.

  2022cites this paper
• Trends, outcomes, and management of acute myocardial infarction in patients with chronic viral hepatitis

  2022cites this paper
• Cardiovascular Evaluation of Liver Transplant Patients by Using Coronary Calcium Scoring in ECG-Synchronized Computed Tomographic Scans

  2021cites this paper
• Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

  2020cites this paper
• One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease

  2020cites this paper
• Cardiovascular assessment in liver transplant candidates

  2020cites this paper
• Trends, management and outcomes of acute myocardial infarction in chronic liver disease

  2020cites this paper
• Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database).

  2020cites this paper
• Liver transplantation and cardiac illness: Current evidences and future directions

  2020cites this paper
• Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis

  2019cites this paper
• Cardiac Evaluation and Management

  2019cites this paper
• Significance of Coronary Artery Calcium Found on Non-Electrocardiogram-Gated Computed Tomography During Preoperative Evaluation for Liver Transplant.

  2019cites this paper
• A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia

  2019cites this paper
• Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized Approach.

  2019cites this paper
• Anticoagulation in the Hospitalized Patient with Decompensated Cirrhosis: Management of a Delicate Balance

  2019cites this paper
• Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations

  2018cites this paper
• Cardiac diseases among liver transplant candidates

  2018cites this paper
• Frequency of Complications Including Death from Coronary Artery Bypass Grafting in Patients With Hepatic Cirrhosis.

  2018cites this paper
• Perioperative Considerations in Liver Transplantation

  2018cites this paper
• The Significance of Coronary Artery Calcification Found on Non-ECG-Gated Computed Tomography During Pre-Operative Evaluation for Liver Transplant

  2018cites this paper
• Liver Transplantation in Patients With Cardiac Disease

  2018cites this paper
• Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality

  2017cites this paper
• International Normalized Ratio Does Not Predict Gastrointestinal Bleeding After Endoscopic Retrograde Cholangiopancreatography in Patients With Cirrhosis

  2017cites this paper
• Role of Coronary Angiography in Pre-Liver Transplantation Cardiac Evaluation: Experience From an Asian Transplant Institution.

  2017cites this paper
• Evaluation of coronary artery disease in potential liver transplant recipients

  2017cites this paper
• Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation

  2016cites this paper
• Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation

  2016cites this paper
• Perioperative Risk Assessment and Management of Cirrhotic Patients

  2015cites this paper
• Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization.

  2015cites this paper
• Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.

  2014cites this paper
• Transradial cardiac catheterization in liver transplant candidates.

  2014cites this paper
• Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation

  2014cites this paper
• Role of cardiovascular intervention as a bridge to liver transplantation.

  2014cites this paper
• Role of baseline echocardiography in the preoperative management of liver transplant candidates.

  2012cites this paper
• Patent foramen ovale and intracardiac thrombus identified by transesophageal echocardiography during liver transplantation.

  2012cites this paper
• Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization.

  2012cites this paper
• Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis

  2012cites this paper
• Coronary Artery Stents and Antiplatelet Therapy in Patients With Cirrhosis

  2012cites this paper
• Feasibility and safety of percutaneous coronary intervention in patients with end‐stage liver disease referred for liver transplantation

  2011cites this paper